In Unregulated African Markets, Chinese Drugs Move In On India Photo: securingindustry.com China has captured “the lion’s share” of India’s bulk drugs industry, and now it’s hurting India’s exports markets — especially in African countries where China is dumping cheap product, Indian stakeholders say. Indian pharmaceutical companies have something else to worry about. China is setting up plants in Africa. Once those are established, China will no longer face anti-dumping duty, according to a report in TimesOfIndia. It’s China’s practice to initially dump cheap products at uncompetitive prices, TimesOfIndia reported.
China promises to build 100 hospitals, clinics in Africa - Footprint to Africa The Chinese government has promised to build 100 hospitals and clinics across Africa in the next three years as part of a plan to improve health systems and preparations for containing future disease outbreaks on the continent. The announcement was made following South African Health Minister Aaron Motsoaledi and his Chinese counterpart Lin Bin’s three-day meeting at the second Ministerial Forum of China-Africa Health Development which has ended in Pretoria. Motsoaledi said the forum, which is a partnership between the Chinese government and those of several African countries, was a major boost to the African continent and would help strengthen the continent’s public health systems during the post-Ebola era.
The Hawn Foundation I love MindUP! It is a way to focus your mind, calm down and reflect on a situation when you need to make a choice. - Tyler G., Seventh Grade Student China and Africa hold talks on health development By Judith Ugwumadu | 27 March 2015 Chinese and African health leaders have called for a strengthened partnership to discuss opportunities for universal health care and access to essential medicines. At an international roundtable meeting, held in Beijing this week, Chinese leaders said they had a ‘unique role to play in supporting Africa’s health progress’ because of China’s advances in research and development and its manufacture of low-cost medicines and vaccines. More than 350 health leaders from China and Africa, including government officials, academics and representatives from the private sector and international organisations, attended the meeting. The Contributing to universal health coverage, expanding access to essential medicines roundtable, called for deepened talks between Chinese, African and international stakeholders, increased investments in health, and alignment with African regional and national strategies.
Umberto Eco Makes a List of the 14 Common Features of Fascism Creative Commons image by Rob Bogaerts, via the National Archives in Holland One of the key questions facing both journalists and loyal oppositions these days is how do we stay honest as euphemisms and trivializations take over the discourse? Can we use words like “fascism,” for example, with fidelity to the meaning of that word in world history? The term, after all, devolved decades after World War II into the trite expression fascist pig, writes Umberto Eco in his 1995 essay “Ur-Fascism,” “used by American radicals thirty years later to refer to a cop who did not approve of their smoking habits.” In the forties, on the other hand, the fight against fascism was a “moral duty for every good American.”
China-Africa joint medical research to deepen [GABORONE, BOTSWANA] China will deepen joint medical research with Africa, particularly in training African medical scientists. Ren Minghui, director-general of the Department for International Cooperation within the National Health and Family Planning Commission of China, said research and development is one priority area of collaboration being explored. "China can support Africa in technical areas of research such as having scientists train in institutions such as the Chinese Center for Disease Control and Prevention, one of the most important institutes in China for research in preventive diseases," he told SciDev.Net at the Fourth International Roundtable on China-Africa Health Cooperation in Botswana, which ended today (7 May). The collaboration aims to boost Africa's research capacityChinese drugs firms are being urged to transfer technologyThe initiative is not driven by commercial interest, says Chinese official "Data are important for decision-making and for knowing where we are.
Epigenetics Technology Market (Epigenomics, DNA Methylation, Histone Modifications) (2012 - 2017) Over the last decade, genomics and proteomics have been used as key tools to discover potential drug targets and to better understand the complexities of biology. To balance research in these areas, epigenetics offers a potential opportunity in understanding the basis of various diseases in a different approach. Thus, epigenetics is study of heritable changes in genome function and gene expression had opened the new gate of biology to understand the basis of diseases and presents incredible opportunities for disease diagnosis and drug discovery. Report covers the market by therapeutics sector in oncology conditions, non-oncology indications and personalized medicine.
Advanced Wound Care Market Research Report, Global Forecasts to 2016 :MarketsandMarkets The global wound care market is expected to reach $18.3 billion by 2019 from $15.6 billion in 2014, growing at a CAGR of 3.2% from 2014 to 2019. The factors driving the market growth include government support in the form of funding for development of wound care products, increasing diabetic and obese population, and rising aging population are providing required impetus for growth of the market. However, factors such as high costs of advanced wound care products may restrain the market growth. North America dominates the wound care market with the U.S. accounting for the major market share. Asia is poised to grow at the highest CAGR during the forecast period, owing to the increasing awareness for wound healing products, rising aging population, rising diabetic wounds due to changing lifestyle factors, and growing population with pressure ulcers. Furthermore, many giant players are focusing on the market in Asia.
Isothermal Nucleic Acid Amplification Technologies (INAAT) Market Report - Forecasts 2012-17 The research analysis titled “Isothermal Nucleic Acid (Gene) Amplification Technologies (INAAT)” discloses the promising trends in Nucleic acid testing and their applications in molecular diagnostics and laboratory research on a global scale. The World Health Organization (WHO) proposes that, an ideal diagnostic test (DNA test kits, RNA test kit etc) that is suitable for developing countries, should be Affordable, Sensitive, Specific and User-friendly (simple to perform in a few steps with minimal training), Robust and rapid (results available in minutes), Equipment free and Deliverable to the end-user (ASSURED). Nucleic acid diagnostics targeting pathogen markers have high sensitivity and specificity, but generally fail to meet the ASSURED guidelines in terms of affordability, rapidity, and being equipment free.
Smart Pill Technology Market, Digital Pills, Capsule Endoscopy Market Size, Forecasts 2012-17 The global smart pills market is segmented on the basis of applications and regions. The market by applications is categorized into capsule endoscopy, drug delivery, and patient monitoring. On the basis of regions, the market is divided into North America, Europe, Asia, and Rest of the World (RoW: Pacific countries, Africa, and Latin America). Factors such as favorable reimbursement scenario, patient preference for minimally invasive procedures, technological advancements in endoscopy procedures, and rising prevalence of colon cancer are driving the growth of this market. Moreover, benefits provided by the smart pills technology such as technological advancements in endoscopy procedures, targeted drug delivery, and easy remote patient monitoring are propelling the adoption of this technology. North America is the largest market in the smart pills.
Autologous Stem Cell Market & Non-stem Cell Therapy Market - Forecasts 2012-17 This research report titled “Autologous Stem Cell and Non-Stem Cell Based Therapies Market (2012-2017)” provides details about various autologous cell based treatments and their application areas. Every health regulatory bodies will be expecting companies and universities to develop therapy treatments, which are Safer, Affordable, Robust, Rapid, Easy to use, Effective and Deliverable to the end user. Autologous stem cell transplantation for particular application areas is safe experiencing robust growth and has minimal steps of procedure to follow and is rapid in deriving the results. The sources for autologous stem cell therapy are Mesenchymal stem cells, Hematopoietic stem cells, Chondrocytes and so on. Currently, the cost of the treatments is not affordable however, by the intrusion of government bodies, this mode of treatment will certainly experience an immense market growth.
Biosimulation Market & Insilico Technology Research Report - Forecasts 2012-17 Biosimulation refers to computer aided simulation of biological processes and systems, an integral part of systems biology used in drug discovery and development. This report will analyze the potential of biosimulation in drug discovery and development. Biosimulation is used across the drug discovery and development program (such as target identification, target validation, lead discovery, lead optimization, preclinical and clinical test). The global biosimulation market was valued at $432 million in 2011 and is expected to reach $1.2 billion by 2017, at a CAGR of 18.5%.
ESL-Kids - In Class - Learning Styles and Classroom Management Name: Hiroki Age: 5 Learning Style: Kinesthetic. Being a kinesthetic learner, Hiroki learns best through physical movement. Total Physical Response (TPR) activities, in which the children respond physically to the teacher's commands, are most appropriate for children like Hiroki. Examples of TPR include forming ABC shapes with the body, actions like running, jumping, or touching things the teacher calls out. In-Vitro Diagnostics (IVD) Market: Clinical Chemistry, Immunoassays, Molecular Diagnostics, Hematology Analyzers & Microbiology Culture – Global Trends & Forecasts to 2016, Market Research Report :MarketsandMarkets Factors such as the continuous technological advancements in the field of diagnostics and an increase in healthcare awareness have made In Vitro Diagnostic testing an indispensable tool in current medical practices. In the report, the market has been segmented on the basis of technology, product type, application, and end-users. On the basis of technology, the molecular diagnostics market is expected to grow at the highest CAGR from 2012 to 2017. The advancements in molecular techniques, increasing awareness and acceptance of personalized medicines, rise in the occurrence of chronic diseases, and the need for the diagnosis of such diseases at early stages are the key factors driving the growth of the molecular diagnostics market. On the other hand, the development of a large variety of reagents and analytical techniques, and inexpensive automated testing known as point-of-care (POC) are the factors leading to the growth in the reagents market.